Get started
BioNTech SEBioNTech SEBioNTech SE

BioNTech SE

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFs

In-depth trading ideas


Discover detailed market analysis from traders. See how others approach this instrument, compare different strategies, and discover perspectives that can shape your own view.
Trade ideasMinds
BioNTech (BNTX) LONG — 4H ALMA Setup (WR 80%)█ SETUP NASDAQ:BNTX · 4H · long only. (Context: BioNTech — mRNA platform; oncology pivot post-COVID; Pfizer Comirnaty partner.) ALMA Averaging Strategy: ALMA 3 / σ2, SD band 2, min diff 6/1, 25% per bar, up to 4 adds, hard stop −10% from average entry. Strategy Tester (BNTX 4H): Win rate 80% · profit factor 2.3 · max drawdown 17% Avg winning trade +10.6% · avg losing trade −8.8% Typical hold ~18×4H bars on winners — biotech mean-reversion sleeve on the US cash grid █ WHY NOW Monda
NASDAQ:BNTXLong
by Goldfinch_song
BioNTech Price Target Cut at Citi Following Co-Founder NewsIn a notable development for shareholders of the German biotechnology giant, Citi has revised its financial outlook for BioNTech SE (NASDAQ: BNTX) . The financial services firm announced it is lowering its price target on the company's shares to $130 from $145 , a reduction of approximately 10%. Despite this downward adjustment to the valuation metric, Citi has opted to maintain its Buy rating on the stock, signaling a nuanced perspective on the company's current trajectory. The decision to tri
NASDAQ:BNTXLong
by KalaGhazi
$BNTX The Founders Left. The Pipeline Didn't.This morning BioNTech dropped a bombshell. Co-founders Prof. Ugur Sahin and Prof. Özlem Türeci, the two scientists who built the mRNA platform that produced the world's first approved COVID-19 vaccine, announced they are leaving the company by end of 2026 to start a new independent mRNA-focused biotech. BioNTech will contribute related mRNA technology rights to the new venture in exchange for a minority stake and potential milestones and royalties. The stock immediately sold off 14%, wiping
NASDAQ:BNTXLong
by ConnectmyCurrency
1/7/26 - BNTX: new BUY mechanical trading signal.1/7/26 - BNTX: new BUY signal chosen by a rules based, mechanical trading system. BNTX - BUY Stop Loss @ 91.11 Entry BUY @ 100.08 Target Profit @ 113.80 Analysis: Higher timeframe: Prices have stayed above the lower channel line of the ATR (Average True Range) Keltner Channel and reversed. Higher timeframe: Victor Sperandeo's (Trader Vic) classic 1-2-3/2B BUY pattern...where the current lowest bottom breakout price is greater or only slightly peaking lower than the preceding bottom price.
NASDAQ:BNTXLong
by martinmlm
Long Thesis on BioNTech SE Post-EarningsBioNTech SE presents a compelling long opportunity following its latest earnings report. The company continues to expand beyond COVID-19 vaccines, with a strong pipeline in personalized mRNA cancer therapies, infectious disease vaccines (HIV, tuberculosis, malaria), and autoimmunity treatments. With €17 billion in cash reserves, minimal debt, and high gross margins (~77%), BioNTech remains financially resilient. Key catalysts for a bullish scenario include: ✅ Successful clinical trials in oncol
NASDAQ:BNTXLong
by rencus30
BioNtech SE(Extended Hours) | Chart & Forecast SummaryKey Indicators On Trade Set Up In General 1. Push Set Up 2. Range Set up 3. Break & Retest Set Up Notes On Session # BioNtech SE(Extended Hours) - Double Formation * Neckline At 88.00 | Double Bottom Confirmation | Subdivision 1 * Support=0 | Failed Target | No Trade - Triple Formation * WXY Wave | Range Structure | Subdivision 2 * Retracement | 0.5 & 0.382 * Trade Execution | Alignment(Short) | Subdivision 3 Active Sessions On Relevant Range & Elemented Probabilities; London(Upwards) - NYC(Do
CAPITALCOM:BNTXLong
by UnknownUnicorn87383881
BioNtech SE (Extended Hours) | Chart & Forecast SummaryKey Indicators On Trade Set Up In General 1. Push Set Up 2. Range Set up 3. Break & Retest Set Up Notes On Session # BioNtech SE (Extended Hours) - Triple Formation * Inverted Head & Shoulders | Subdivision 1 * 012345 | Failed Attempt | No Trade! * Triangle Structure | Bearish Continuation | Subdivision 2 - Double Formation * Retracement | 0.5 | Uptrend Bias * Second Shoulder | Subdivision 3 Active Sessions On Relevant Range & Elemented Probabilities; London(Upwards) - NYC(Downwards) Conclusi
CAPITALCOM:BNTXLong
by UnknownUnicorn87383881
BNTX’s Next ChapterBioNTech is building strong bullish momentum, with a gap forming around the $93.00 level. A breakout above the $125.83 resistance would confirm further upward movement, positioning the stock to target the $172.41 gap-fill resistance. This trade offers an attractive risk-to-reward ratio, with a stop-loss set at $90.00 to effectively manage downside risk. BioNTech’s continued advancements in mRNA technology, along with its expanding pipeline of vaccines and immunotherapies, bolster its long-term
NASDAQ:BNTXLong
by The_Trading_Mechanic